IAM
GILD icon

Impax Asset Management’s Gilead Sciences GILD Stock Holding History

Impax Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-181,151
Closed -$14.7M – 199
2017
Q3 		$14.7M Hold
181,151
– – 0.84% 52
2017
Q2 		$12.8M Sell
181,151
-218
-0.1% -$14.5K 0.72% 65
2017
Q1 		$12.3M Buy
181,369
+10,002
+6% +$703K 0.69% 65
2016
Q4 		$12.3M Buy
171,367
+42,586
+33% +$3.17M 0.7% 68
2016
Q3 		$10.2M Buy
128,781
+35,772
+38% +$2.91M 0.58% 81
2016
Q2 		$7.76M Sell
93,009
-34,749
-27% -$3.08M 0.45% 91
2016
Q1 		$11.7M Sell
127,758
-57,396
-31% -$5.18M 0.63% 65
2015
Q4 		$18.7M Buy
185,154
+44,068
+31% +$4.59M 1.04% 34
2015
Q3 		$13.9M Sell
141,086
-21,630
-13% -$2.4M 0.82% 48
2015
Q2 		$19.1M Sell
162,716
-264
-0.2% -$28.8K 1.02% 33
2015
Q1 		$16M Sell
162,980
-67,457
-29% -$6.85M 0.88% 44
2014
Q4 		$21.7M Sell
230,437
-33,735
-13% -$3.49M 1.29% 27
2014
Q3 		$28.1M Sell
264,172
-59,225
-18% -$5.8M 1.82% 12
2014
Q2 		$26.8M Sell
323,397
-15,126
-4% -$1.18M 1.69% 15
2014
Q1 		$24M Buy
338,523
+136
+0% +$10.7K 1.54% 18
2013
Q4 		$25.4M Buy
338,387
+160,093
+90% +$11.1M 1.61% 16
2013
Q3 		$11.2M Buy
178,294
+101,339
+132% +$6.06M 0.75% 56
2013
Q2 		$3.94M Buy
+76,955
New +$4.01M 0.27% 84

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Impax Asset Management's GILD Position: Q4 2017 in Review

Impax Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 181,151 shares — an estimated $14.7M sold.

Impax Asset Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $28.1M in Q3 2014. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Impax Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Impax Asset Management sold 181,151 Gilead Sciences shares in Q4 2017, an estimated $14.7M.
  • Impax Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Impax Asset Management's Gilead Sciences position peaked at $28.1M in Q3 2014.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Impax Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.